The Media Preparation Core Facility provides CCR members and their laboratories with immediate access to a wide variety of culture media and sterile solutions that are critical for their research programs. This includes both standard formulations of bacterial and tissue culture media as well as custom-made yeast medias. The Media Preparation Core Facility also provides specialized media to the Transgenic Animal Core Facility. The media facility is highly reliable, producing a comprehensive panel of reagents that are of outstanding quality and, in many cases, not available from commercial sources. A significant fraction of the facilities operating costs are recovered by per-item chargebacks. The centralization of these services allows the CCR to minimize staff costs and space requirements while maximizing efficiency and cost-effectiveness. Price comparisons with commercial sources (for those items that are commercially available) show that the resulting costs to CCR Investigators are highly competitive. Moreover, outsourcing of these services would preclude us from providing the non-commercially available media that are critical for several of our members. Therefore, the Media Preparation Core Facility is a key resource for CCR researchers and represents excellent value for the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-38
Application #
7849613
Study Section
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
38
Fiscal Year
2009
Total Cost
$179,047
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Guen, Vincent J; Edvardson, Simon; Fraenkel, Nitay D et al. (2018) A homozygous deleterious CDK10 mutation in a patient with agenesis of corpus callosum, retinopathy, and deafness. Am J Med Genet A 176:92-98
Murphy, Patrick A; Butty, Vincent L; Boutz, Paul L et al. (2018) Alternative RNA splicing in the endothelium mediated in part by Rbfox2 regulates the arterial response to low flow. Elife 7:
Khan, Omar F; Kowalski, Piotr S; Doloff, Joshua C et al. (2018) Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles. Sci Adv 4:eaar8409
Woolston, Benjamin M; Roth, Timothy; Kohale, Ishwar et al. (2018) Development of a formaldehyde biosensor with application to synthetic methylotrophy. Biotechnol Bioeng 115:206-215
Huang, Hsin-Ho; Qian, Yili; Del Vecchio, Domitilla (2018) A quasi-integral controller for adaptation of genetic modules to variable ribosome demand. Nat Commun 9:5415
GuimarĂ£es, Pedro P G; Gaglione, Stephanie; Sewastianik, Tomasz et al. (2018) Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy. ACS Nano 12:912-931
Moynihan, Kelly D; Holden, Rebecca L; Mehta, Naveen K et al. (2018) Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability. Cancer Immunol Res 6:1025-1038
Nath, Samir R; Yu, Zhigang; Gipson, Theresa A et al. (2018) Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction. J Clin Invest 128:3630-3641
Kimmerling, Robert J; Prakadan, Sanjay M; Gupta, Alejandro J et al. (2018) Linking single-cell measurements of mass, growth rate, and gene expression. Genome Biol 19:207
Rothenberg, Daniel A; Taliaferro, J Matthew; Huber, Sabrina M et al. (2018) A Proteomics Approach to Profiling the Temporal Translational Response to Stress and Growth. iScience 9:367-381

Showing the most recent 10 out of 904 publications